Atlas of Clinical Positron Emission Tomography 2nd Edition
Positron Emission Tomography (PET) is now firmly established as an invaluable technique for diagnosing and monitoring disease. The second edition of this comprehensive clinical atlas will continue to present the combined experience of two of the world's leading PET centres as the technique has moved on from its formative years to gain established value in clinical practice. The book has been substantially rewritten to take account of the exciting developments that are occurring with the introduction of PET/CT, and new &‘state-of-the-art&’ PET/CT images are presented. The new edition continues to be presented as a series of 'mini-lectures' carefully designed for rapid assimilation, illustrated by case histories in which high-quality illustrations are supplemented by clear concise teaching points and directions for further reading.
Part One provides an excellent introduction to the science and practice of PET and displays normal variants and discusses potential pitfalls. In Part Two, the applications of PET/CT in oncology are covered in detail, according to body system in order of their clinical importance. Part Three examines the applications of PET/CT beyond oncology; in neuropsychiatry, cardiology and infection.
A useful additional feature is the accompanying DVD-Rom with HERMES RAPID software, which contains PET/CT cases for viewing and analysis, with cross-modality image fusion, and has been provided by Hermes Medical Solutions.
Atlas of Clinical Positron Emission Tomography is an invaluable resource for nuclear medicine specialists, radiologists and oncologists, both in training and in practice.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
activity adenocarcinoma artefacts assessment axillary benign biopsy bone brain tumors breast cancer cervical cancer chemotherapy Clinical history colorectal cancer computed tomography CT scan detection Diagnosis differentiate epilepsy esophageal cancer evaluation FDG PET FDG uptake fluorodeoxyglucose gland glucose head and neck high uptake hypometabolism increased uptake infection JNucl KEY MANAGEMENT ISSUES Key point lesion liver low-grade lung cancer lymph nodes lymphoma malignant mediastinal mediastinum melanoma metastases metastatic disease Mol Imaging myocardium neck cancer normal Nucl patient was referred percent PET and PET/CT PET findings PET imaging PET scan PET was requested PET/CT findings PET/CT was requested physiologic uptake positron emission tomography primary tumor prognosis prostate cancer radiation Radiology radiotherapy region renal cancers requested to characterize requested to determine resection restaging Role of PET scanner seen sensitivity soft-tissue staging studies surgery surgical therapy thyroid cancer tissue tracer uptake treatment response uptake of FDG Wahl RL whole-body